Cutler Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,700
Closed -$12K 3746
2023
Q1
$12K Sell
8,700
-11,300
-57% -$888K ﹤0.01% 2201
2022
Q4
$55K Buy
20,000
+18,600
+1,329% +$1.43M ﹤0.01% 1501
2022
Q3
$24K Sell
1,400
-1,000
-42% -$96.2K ﹤0.01% 2472
2022
Q2
$25K Sell
2,400
-3,200
-57% -$331K ﹤0.01% 2482
2022
Q1
$2K Buy
+5,600
New +$628K ﹤0.01% 4654
2018
Q2
Sell
-2,400
Closed -$1K 4372
2018
Q1
$1K Sell
2,400
-10,800
-82% -$469K ﹤0.01% 4026
2017
Q4
$8K Sell
13,200
-41,100
-76% -$1.51M ﹤0.01% 3291
2017
Q3
$40K Buy
54,300
+12,600
+30% +$481K ﹤0.01% 2451
2017
Q2
$24K Buy
41,700
+11,400
+38% +$416K ﹤0.01% 3220
2017
Q1
$13K Sell
30,300
-66,900
-69% -$2.09M ﹤0.01% 3780
2016
Q4
$115K Buy
97,200
+20,100
+26% +$651K ﹤0.01% 1774
2016
Q3
$32K Sell
77,100
-97,200
-56% -$3.66M ﹤0.01% 2925
2016
Q2
$227K Buy
174,300
+39,600
+29% +$1.35M 0.01% 1023
2016
Q1
$62K Buy
134,700
+56,700
+73% +$1.56M ﹤0.01% 2092
2015
Q4
$40K Buy
+78,000
New +$2.03M ﹤0.01% 2696

Other funds holding EW

Cutler Group's EW Position: Q1 2024 in Review

Cutler Group sold out of Edwards Lifesciences (EW) in Q1 2024, closing a stake of 207 shares — an estimated $15K sold.

Cutler Group first reported a position in EW in Q4 2015 and held it in 17 quarters. The position peaked at $2.29M in Q2 2016. 1,279 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Cutler Group reported no remaining Edwards Lifesciences position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 207 Edwards Lifesciences shares in Q1 2024, an estimated $15K.
  • Cutler Group first reported a position in Edwards Lifesciences in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Edwards Lifesciences position peaked at $2.29M in Q2 2016.
  • 1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.